FTC Claims Win as Fairfield Medical Center Chooses Smaller Suitor Over OhioHealth

For the patients of Fairfield County, Ohio, the difference between two hospital mergers might sound like inside-baseball finance. It isn't. Who owns your local hospital shapes how much you pay for a knee replacement, how long you wait for a bed, and whether your insurer has any leverage to keep prices in check. That's the real stakes behind a deal that closed this past week, one federal regulators are now calling a model for how struggling hospitals should search for a buyer.

The 222-bed Fairfield Medical Center had been heading toward a very different outcome. In late 2024, the hospital signed a non-binding letter of intent to potentially join OhioHealth, a 16-hospital system with substantial market presence in the region. Instead, Fairfield finalized its acquisition this week by Adena Health, a considerably smaller five-hospital system, just months after the two sides disclosed their own non-binding letter of intent.

"Our responsibility has always been to ensure Fairfield Medical Center is positioned to serve our communities well into the future," John R. "Jack" Janoso Jr., the hospital's president and CEO, said in the announcement. "I believe joining Adena Health provides that strong path forward, and I am confident in all that is ahead."

The Federal Trade Commission wasted no time claiming credit for the switch. In a Wednesday release, the agency said it and the Ohio Attorney General's Office had investigated the original OhioHealth proposal and found it would have "threatened substantially to reduce competition among hospitals in this region, risking higher costs and diminished quality of care for patients across southeastern Ohio," FTC Chairman Andrew Ferguson said.

Regulators say they pushed Fairfield to widen its search. That encouragement, officials claim, led the hospital to draw interest from multiple potential buyers before settling on Adena, a system that, crucially for antitrust purposes, did not already operate a hospital in Fairfield County or the surrounding area.

"The Commission remains vigilant in preserving healthcare competition, especially when reviewing deals involving hospitals that serve rural communities," FTC Bureau of Competition Director Daniel Guarnera said in a statement. "Today's announcement should serve as a reminder that we will stop bad hospital deals."

What the FTC Expects From a "Good-Faith" Shop Process

Think of a hospital sale like selling a family home under financial pressure. You could take the first offer from the neighbor who's been eyeing your lot for years, even if that neighbor already controls half the block. Or you could hold an honest, open listing and let the market decide. The FTC's argument here is essentially that struggling hospitals owe patients the second approach, not the first.

Ferguson's accompanying statement laid out that standard in detail. Citing the FTC's Merger Guidelines and longstanding Supreme Court precedent, he explained that a hospital in financial trouble can only invoke a "failing firm defense" for an otherwise anticompetitive deal under narrow conditions. There must be a "grave probability of a business failure." The prospects for a bankruptcy reorganization must be "dim or nonexistent." And the buyer in question must be the "only available purchaser" after a genuine, good-faith search.

"The mere fact, then, that a close competitor is willing to buy the financially distressed hospital is not sufficient to justify an otherwise unlawful risk of harm to patients and healthcare workers," Ferguson wrote. It's a pointed line, and one clearly aimed at hospital boards elsewhere who might assume desperation alone justifies a deal with the biggest, closest buyer.

Ferguson's statement also spelled out how FTC staff actually evaluate whether a sale process passes muster. Investigators look at whether the seller solicited a full set of potential buyers, whether those buyers had enough time and information to make a real offer, whether the seller negotiated in good faith, and whether the seller gave appropriate weight to bids that wouldn't raise competitive red flags. Ferguson noted that following those steps isn't just good antitrust hygiene. It's often in the seller's own financial interest, since a broader search "may yield more attractive offers than a truncated sales process to a handful of bidders."

But there's a hard line drawn underneath that encouragement. "If that search process yields an offer that would preserve competition, rather than substantially lessen it, the seller may not accept the anticompetitive offer even if it is more lucrative to do so," Ferguson wrote. In other words, a bigger check from a dominant competitor doesn't override the public interest in keeping multiple hospitals genuinely competing for patients.

With the Fairfield deal closed, Adena Health now operates five hospitals and more than 50 locations spread across 11 central and southern Ohio counties, employing roughly 6,000 people. The system reported $815 million in total revenue for fiscal year 2025, with a modest $7.2 million operating income, a 0.9% operating margin that underscores just how thin the financial cushion is for many regional health systems even after a successful acquisition.

OhioHealth's absence from the winning side of this deal fits a broader pattern of scrutiny the system has faced. In February, the Ohio attorney general and the Department of Justice alleged that OhioHealth used its market strength to "force" insurers into noncompetitive contracts. The system reached a settlement with the government in June, though OhioHealth has not admitted wrongdoing and maintains its contracting practices were, and remain, lawful and appropriate.

Why It Matters

Rural and semi-rural hospitals across the country are facing the same pressures that pushed Fairfield toward a merger in the first place: thin margins, workforce shortages, and rising costs of care. Many will look to consolidation as their only path to survival, and that instinct is understandable. But this case signals that regulators are watching those deals closely, and that "we had no other choice" won't be accepted at face value anymore.

For patients in southeastern Ohio, the practical difference may not be felt immediately. Adena's own financial position is tight enough that its long-term ability to invest in Fairfield's facility remains an open question. Still, the FTC's message to hospital boards nationwide is clear: financial distress can explain a merger, but it can't excuse one that leaves patients with fewer choices and less leverage over their own care.